Literature DB >> 34854015

Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates.

Malek Namaki1, Shahram Habibzadeh2, Hamid Vaez3, Mohsen Arzanlou1, Somayeh Safarirad1, Seyed Ali Bazghandi1, Amirhossein Sahebkar4,5,6,7, Farzad Khademi8.   

Abstract

BACKGROUND: Biocides are frequently used as preservative, disinfectant and sterilizer against many microorganisms in hospitals, industry and home. However, the reduced susceptibility rate of Pseudomonas aeruginosa (P. aeruginosa) strains to biocides is increasing. The aim of this study was to evaluate the antimicrobial activity of four frequently used biocides against P. aeruginosa and to determine the prevalence of genes involved in biocide resistance.
METHODS: A total of 76 clinical isolates of P. aeruginosa strains were used in the present study. The minimum inhibitory concentrations (MICs) of four biocides, i.e. chlorhexidine digluconate, benzalkonium chloride, triclosan and formaldehyde, against P. aeruginosa strains were determined using agar dilution method. In addition, the prevalence of biocide resistance genes was determined using the polymerase chain reaction (PCR) method.
RESULTS: In the present study, the highest MIC90 and MIC95 (epidemiological cut-off) values were observed for benzalkonium chloride (1024 μg/mL), followed by formaldehyde (512 μg/mL), triclosan (512 μg/mL) and chlorhexidine digluconate (64 μg/mL). Furthermore, the prevalence of qacEΔ1, qacE, qacG, fabV, cepA and fabI genes were 73.7% (n = 56), 26.3% (n = 20), 11.8% (n = 9), 84.2% (n = 64), 81.5% (n = 62) and 0% (n = 0), respectively. A significant association was observed between the presence of biocide resistance genes and MICs (p < 0.05). Furthermore, there was no significant association between the presence of biocide resistance genes and antibiotic resistance (p > 0.05), except for levofloxacin and norfloxacin antibiotics and qacE and qacG genes (p < 0.05).
CONCLUSION: Our results revealed that chlorhexidine digluconate is the most effective biocide against P. aeruginosa isolates in Ardabil hospitals. However, we recommend continuous monitoring of the antimicrobial activity of biocides and the prevalence of biocide-associated resistance genes for a better prevention of microorganism dissemination and infection control in hospitals.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Benzalkonium chloride; Chlorhexidine digluconate; Formaldehyde; Pseudomonas aeruginosa; Resistance; Triclosan

Mesh:

Substances:

Year:  2021        PMID: 34854015     DOI: 10.1007/s11033-021-07032-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  2 in total

1.  Molecular detection of carbapenem-resistant genes in clinical isolates of Klebsiella pneumoniae.

Authors:  A Delarampour; Z R Ghalehnoo; F Khademi; M Delarampour; H Vaez
Journal:  Ann Ig       Date:  2019 Jul-Aug

2.  Functional Characterization of Triclosan-Resistant Enoyl-acyl-carrier Protein Reductase (FabV) in Pseudomonas aeruginosa.

Authors:  Yong-Heng Huang; Jin-Shui Lin; Jin-Cheng Ma; Hai-Hong Wang
Journal:  Front Microbiol       Date:  2016-11-29       Impact factor: 5.640

  2 in total
  2 in total

1.  Antimicrobial Biocides Susceptibility and Tolerance-Associated Genes in Enterococcus faecalis and Enterococcus faecium Isolates Collected from Human and Environmental Sources.

Authors:  Malek Namaki Kheljan; Roghayeh Teymorpour; Hadi Peeri Doghaheh; Mohsen Arzanlou
Journal:  Curr Microbiol       Date:  2022-04-27       Impact factor: 2.188

2.  Pseudomonas aeruginosa Detection Using Conventional PCR and Quantitative Real-Time PCR Based on Species-Specific Novel Gene Targets Identified by Pangenome Analysis.

Authors:  Chufang Wang; Qinghua Ye; Aiming Jiang; Jumei Zhang; Yuting Shang; Fan Li; Baoqing Zhou; Xinran Xiang; Qihui Gu; Rui Pang; Yu Ding; Shi Wu; Moutong Chen; Qingping Wu; Juan Wang
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.